Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally.
Level 5 - mechanism / opinion, no new human data
Animal research (gerbil model) examining biochemical brain outcomes
PubMed 16631143 · doi:10.1016/j.brainres.2006.03.019
What was done
Gerbils received daily oral supplementation for up to 4 weeks with a diet containing choline chloride and uridine-5'-monophosphate (UMP, a uridine source), DHA by gavage, or a combination of both. Brain tissue was analyzed across 1 to 4 weeks to measure levels of membrane phosphatides (phosphatidylcholine, phosphatidylethanolamine, and others) and specific synaptic and neurite proteins (Synapsin-1, PSD-95, NF-70, NF-M, and beta-tubulin).
What was found
After 4 weeks, brain phosphatidylcholine increased by 13-22% with uridine plus choline alone or DHA alone, and by 45% with the combination. Phosphatidylethanolamine and other phosphatides increased by 39-74% with the combination. The combination also increased Synapsin-1 by 41%, PSD-95 by 38%, NF-70 by up to 102%, and NF-M by 48%. Beta-tubulin levels were unchanged. Smaller elevations in phosphatides occurred after 1-3 weeks.
Why it matters
The study demonstrates that oral administration of the phosphatide precursors uridine, DHA, and choline can synergistically elevate membrane phospholipid synthesis and synaptic proteins in an animal model.
Limits
The study was conducted entirely in gerbils, precluding direct clinical conclusions for humans or Alzheimer's disease. The abstract omits sample size (n), specific dosages, measures of variance, and statistical significance values. Cognitive and functional outcomes were not assessed.
Cited by
- supports Richard Wurtman from MIT showed that synaptic formation nutritionally requires both DHA and citicoline.